Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
AbbVie will showcase data on ABBV-969, a first-in-class dual-targeted antibody-drug conjugate for metastatic castration-resistant prostate cancer, currently in Phase 1 clinical trials.
ABBV-969, an investigational drug, is under evaluation in a Phase 1 trial for metastatic castration-resistant prostate cancer (mCRPC) treatment.